These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Building predictive ADMET models for early decisions in drug discovery. Penzotti JE; Landrum GA; Putta S Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148 [TBL] [Abstract][Full Text] [Related]
23. Resurrection men dig through the drug graveyard: ARYx revives problem blockbuster drugs. Wolfson W Chem Biol; 2005 Nov; 12(11):1155-6. PubMed ID: 16298292 [No Abstract] [Full Text] [Related]
24. Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations. Gabrielsson J; Dolgos H; Gillberg PG; Bredberg U; Benthem B; Duker G Drug Discov Today; 2009 Apr; 14(7-8):358-72. PubMed ID: 19162219 [TBL] [Abstract][Full Text] [Related]
25. [Safety assessment of new products developed by the pharmaceutical industry]. Claude JR Ann Pharm Fr; 2001 Sep; 59(5):324-30. PubMed ID: 11787426 [TBL] [Abstract][Full Text] [Related]
26. Natural products to drugs: natural product derived compounds in clinical trials. Butler MS Nat Prod Rep; 2005 Apr; 22(2):162-95. PubMed ID: 15806196 [TBL] [Abstract][Full Text] [Related]
27. Natural products to drugs: natural product-derived compounds in clinical trials. Butler MS Nat Prod Rep; 2008 Jun; 25(3):475-516. PubMed ID: 18497896 [TBL] [Abstract][Full Text] [Related]
28. Strength and honor through the pharmaceutical industry's embrace of green chemistry? Fortunak J; Confalone PN; Grosso JA Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518 [No Abstract] [Full Text] [Related]
30. The role of natural product chemistry in drug discovery. Butler MS J Nat Prod; 2004 Dec; 67(12):2141-53. PubMed ID: 15620274 [TBL] [Abstract][Full Text] [Related]
31. Redesigner drugs. Dove A Nat Biotechnol; 2004 Aug; 22(8):953-7. PubMed ID: 15286643 [TBL] [Abstract][Full Text] [Related]
32. From genes to products: innovations in drug discovery. Afshar M Drug Discov Today; 2003 May; 8(9):392-4. PubMed ID: 12706655 [No Abstract] [Full Text] [Related]
33. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk. Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527 [No Abstract] [Full Text] [Related]
34. [Epidemiology and the pharmaceutical industry]. Walker AM; García Rodríguez LA; Pérez Gutthann S Med Clin (Barc); 1992 Mar; 98(12):465-8. PubMed ID: 1573915 [No Abstract] [Full Text] [Related]
35. Toxicity testing in the 21st century: a view from the pharmaceutical industry. MacDonald JS; Robertson RT Toxicol Sci; 2009 Jul; 110(1):40-6. PubMed ID: 19435982 [No Abstract] [Full Text] [Related]
36. From knowing to controlling: a path from genomics to drugs using small molecule probes. Strausberg RL; Schreiber SL Science; 2003 Apr; 300(5617):294-5. PubMed ID: 12690189 [TBL] [Abstract][Full Text] [Related]
37. Growing pains in AIDS drug development. Herrera S Nat Biotechnol; 2004 Oct; 22(10):1194. PubMed ID: 15470440 [No Abstract] [Full Text] [Related]
39. Facts, figures and trends in lead generation. Deprez-Poulain R; Deprez B Curr Top Med Chem; 2004; 4(6):569-80. PubMed ID: 14965294 [TBL] [Abstract][Full Text] [Related]